DG
GILD icon

Delek Group’s Gilead Sciences GILD Stock Holding History

Delek Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$16.6M Sell
250,400
-35,636
-12% -$2.34M 0.64% 61
2019
Q1 		$18.5M Sell
286,036
-7,353
-3% -$489K 0.77% 50
2018
Q4 		$19M Buy
293,389
+21,963
+8% +$1.54M 0.87% 35
2018
Q3 		$20.8M Sell
271,426
-49,067
-15% -$3.71M 0.87% 28
2018
Q2 		$22.7M Buy
320,493
+93,052
+41% +$6.57M 0.97% 22
2018
Q1 		$17.2M Buy
227,441
+8,840
+4% +$703K 0.88% 28
2017
Q4 		$15.6M Buy
+218,601
New +$16.6M 0.84% 31

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Delek Group's GILD Position: Q2 2019 in Review

Delek Group reduced its Gilead Sciences (GILD) stake by 12% in Q2 2019, selling an estimated $2.34M and leaving 250,400 shares worth $16.6M. The position accounts for 0.64% of the portfolio, ranked #61.

Delek Group first reported a position in GILD in Q4 2017 and has held it in 7 quarters since. The position peaked at $22.7M in Q2 2018. 1,483 funds tracked by Wall St. Rank hold GILD as of Q2 2019.

  • Delek Group held 250,400 shares of Gilead Sciences worth $16.6M as of Q2 2019.
  • Delek Group sold 35,636 Gilead Sciences shares in Q2 2019, an estimated $2.34M.
  • Gilead Sciences made up 0.64% of Delek Group's portfolio in Q2 2019, its #61 holding.
  • Delek Group first reported a position in Gilead Sciences in Q4 2017 and has held it in 7 quarters since.
  • Delek Group's Gilead Sciences position peaked at $22.7M in Q2 2018.
  • 1,483 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2019.

Based on Delek Group's 13F filing for Q2 2019, filed 8 Aug 2019.